Skip to main content
Veterinary Medicines

SEPTICINE PA

Suspended
  • Hydrargyrum bicyanatum C7
  • SOLIDAGO VIRGAUREA C1
  • NAJA NAJA C7
  • Phytolacca americana C7
  • ECHINACEA D2
  • Baptisia tinctoria C7
  • Atropa bella-donna C7
  • Secale cornutum C7

Product identification

Medicine name:
SEPTICINE PA
Active substance:
  • Hydrargyrum bicyanatum C7
  • SOLIDAGO VIRGAUREA C1
  • NAJA NAJA C7
  • Phytolacca americana C7
  • ECHINACEA D2
  • Baptisia tinctoria C7
  • Atropa bella-donna C7
  • Secale cornutum C7
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Hydrargyrum bicyanatum C7
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • SOLIDAGO VIRGAUREA C1
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • NAJA NAJA C7
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • Phytolacca americana C7
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • ECHINACEA D2
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • Baptisia tinctoria C7
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • Atropa bella-donna C7
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • Secale cornutum C7
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Authorisation status:
  • Suspended
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boiron
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boiron
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5824471 1/2012
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 14/05/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."